Patrick Soon-Shiong

Patrick Soon-Shiong invented cancer drug, Abraxane. It became a blockbuster thanks to its efficacy against pancreatic cancer. He sold drug companies Abraxis and American Pharmaceutical Partners for a combined $9.1 billion.His biotech startup, NantHealth, went public in 2016; his cancer drug maker, NantKwest, listed in 2015.He owns NantWorks, a network of health startups, and has stakes in media firm tronc and the Los Angeles Lakers.He bought the Los Angeles Times and San Diego Tribune for $500 million in June 2018.